Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
10 Results Found
AHA 2025 Advocacy Agenda
Explore the AHA's 2024 Advocacy Agenda focusing on healthcare policy and advocacy priorities. Download the PDF for detailed information.
AHA Urges Administration to Grant Exceptions for Current and Proposed Tariffs for Medications and Medical Supplies
The AHA late yesterday told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
Home Health PPS Proposed Rule for CY 2025
On June 26, the Centers for Medicare & Medicaid Services (CMS) issued its calendar year (CY) 2025 proposed rule for the home health (HH) prospective payment system (PPS). CMS’ continued application of such large behavioral adjustments may threaten access to HH care for beneficiaries and, in doing so, also negatively impact care for other patients in need of acute hospital services by preventing hospitals and health systems from discharging patients in a timely manner.
New Resources Available to Help Hospitals and Health Systems Continue to Advance Patient Safety Efforts
Leaders representing more than 1,500 hospitals, health systems and other organizations are participating in the Patient Safety Initiative. The focus areas for 2024 include fostering a culture of safety from the board room to the bedside, identifying and addressing inequities in safety, and enhancing workforce safety. If your organization has not joined the Patient Safety Initiative, you can sign up. See details.
FDA Issues Final Rule to Regulate Laboratory Developed Tests as Medical Devices
The Food and Drug Administration (FDA) on April 29 issued a final rule that will phase out, over four years, its general enforcement discretion approach for in vitro diagnostic tests (IVDs), which include laboratory developed tests (LDTs).
Advisory: AHE Member Communication Regarding Ongoing CRE Outbreak Investigation
Advisory
Two very important updates regarding CRE and Shigella sonnei outbreak investigations.
Advisory: Immediate Need for Healthcare Facilities to Review Procedures
Advisory
As a follow-up to a health update entitled HAN 00382 and distributed by Centers for Disease Control and Prevention (CDC) on September 11, 2015, the CDC and U.S. Food and Drug Administration (FDA) are providing this update to rescind the following recommendation.
Advisory: Hand and Environmental Hygiene: Preventing Pathogen Transmission
Advisory
Recent outbreaks of acute flaccid myelitis (AFM) and adenovirus among children have raised questions about ways to prevent transmission when those affected are admitted to a health care facility. This advisory offers information regarding AFM, viruses that are currently implicated, modes of transmission and measures of prevention.
Announcement of GUDID Release 2.2 Deployment and Document Updates
Advisory
An announcement of GUDID Release 2.2 deployment and document updates.
FDA Releases Proposed Rule on Unique Device System for Medical Devices
Advisory
The FDA UDI ruling has finally arrived - the proposed rule has published.